Estrogen Sensitivity and Ovulatory Dysfunction in Obesity

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
ObesityInfertility
Interventions
DRUG

Estradiol

Subjects were instructed to apply 0.1 mg/d transdermal estrogen for one month.

DRUG

Gonadotropin-releasing hormone (GnRH)

Pituitary response was assessed to determine how estradiol administration alters pituitary sensitivity to GnRH.

DRUG

Progesterone

Subjects who failed to initiate a menstrual period following 40 days on the patch were instructed to take 200 mg daily of progesterone for 10 days or as long as deemed necessary.

Trial Locations (1)

80045

University of Colorado, Anschutz Medical Campus, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT01381016 - Estrogen Sensitivity and Ovulatory Dysfunction in Obesity | Biotech Hunter | Biotech Hunter